{'Year': '2012', 'Month': 'Jul'}
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.
The aim of this study was to evaluate the association of gemcitabine pathway SNPs with detailed pharmacokinetic measures obtained from solid tumor patients receiving gemcitabine-based therapy.